Mechanism of UV-related carcinogenesis and its contribution to nevi/melanoma

References

• Slominski A, Pawelek J. Animals under the sun: effects of UV radiation on mammalian skin. Clin. Dermatol.16, 503–515 (1998).
   PubMedGoogle Scholar
• Brenner M, Degitz K, Besch R, Berking C. Differential expression of melanoma-associated growth factors in keratinocytes and fibroblasts by ultraviolet A and ultraviolet B radiation. Br. J. Dermatol.153(4), 733–739 (2005).
   PubMed Web of Science ®Google Scholar
• Norval M. The mechanisms and consequences of ultraviolet-induced immunosuppression. Prog. Biophys. Mol. Biol.92(1), 108–118 (2006).
   PubMed Web of Science ®Google Scholar
• Jhappan C, Noonan FP, Merlino G. Ultraviolet radiation and cutaneous malignant melanoma. Oncogene22(20), 3099–3112 (2003).
   PubMed Web of Science ®Google Scholar
• Mariutti G, Matzeu M. Measurement of ultraviolet radiation emitted from welding arcs. Health Phys.54(5), 529–532 (1988).
   Google Scholar
• Kohen E, Santus R, Hirschberg JG. Photobiology. Academic Press Inc., CA, USA (1995).
   Google Scholar
• Gambichler T, Breuckmann F, Boms S, Altmeyer P, Kreuter A. Narrowband UVB phototherapy in skin conditions beyond psoriasis. J. Am. Acad. Dermatol.52(4), 660–670 (2005).
   PubMed Web of Science ®Google Scholar
• Barbagallo J, Spann CT, Tutrone WD, Weinberg JM. Narrowband UVB phototherapy for the treatment of psoriasis: a review and update. Cutis68(5), 345–347 (2001).
   PubMed Web of Science ®Google Scholar
• Ledo E, Ledo A. Phototherapy, photochemotherapy, and photodynamic therapy: unapproved uses or indications. Clin. Dermatol.18(1), 77–86 (2000).
   Google Scholar
• Gasparro FP. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence. Am. J. Clin. Dermatol.1(6), 337–348 (2000).
   Google Scholar
• Breuckmann F, Gambichler T, Altmeyer P, Kreuter A. UVA/UVA1 phototherapy and puva photochemotherapy in connective tissue diseases and related disorders: a research based review. BMC Dermatol.4(1), 11 (2004).
   PubMedGoogle Scholar
• Scheinfeld N, Deleo V. A review of studies that have utilized different combinations of psoralen and ultraviolet B phototherapy and ultraviolet A phototherapy. Dermatol. Online J.9(5), 7 (2003).
   Google Scholar
• Lee E, Koo J, Berger T. UVB phototherapy and skin cancer risk: a review of the literature. Int. J. Dermatol.44(5), 355–360 (2005).
   PubMed Web of Science ®Google Scholar
• Douki T, Reynaud-Angelin A, Cadet J, Sage E. Bipyrimidine photoproducts rather than oxidative lesions are the main type of DNA damage involved in the genotoxic effect of solar UVA radiation. Biochemistry42(30), 9221–9226 (2003).
   PubMed Web of Science ®Google Scholar
• Courdavault S, Baudouin C, Charveron M et al. Repair of the three main types of bipyrimidine DNA photoproducts in human keratinocytes exposed to UVB and UVA radiations. DNA Repair (Amst.)4(7), 836–844 (2005).
   PubMed Web of Science ®Google Scholar
• Agar NS, Halliday GM, Barnetson RS, Ananthaswamy HN, Wheeler M, Jones AM. The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. Proc. Natl Acad. Sci. USA101(14), 4954–4959 (2004).
   PubMed Web of Science ®Google Scholar
• Brash DE. Roles of the transcription factor p53 in keratinocyte carcinomas. Br. J. Dermatol.154(Suppl. 1), 8–10 (2006).
   Google Scholar
• Heck DE, Vetrano AM, Mariano TM, Laskin JD. UVB light stimulates production of reactive oxygen species: unexpected role for catalase. J. Biol. Chem.278(25), 22432–22436 (2003).
   PubMed Web of Science ®Google Scholar
• Drobetsky EA, Turcotte J, Chateauneuf A. A role for ultraviolet A in solar mutagenesis. Proc. Natl Acad. Sci. USA92(6), 2350–2354 (1995).
   PubMed Web of Science ®Google Scholar
• Besaratinia A, Synold TW, Xi B, Pfeifer GP. G-to-T transversions and small tandem base deletions are the hallmark of mutations induced by ultraviolet A radiation in mammalian cells. Biochemistry43(25), 8169–8177 (2004).
   PubMed Web of Science ®Google Scholar
• Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature411(6835), 366–374 (2001).
   PubMed Web of Science ®Google Scholar
• Giglia G, Dumaz N, Drougard C, Avril MF, Daya-Grosjean L, Sarasin A. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C. Cancer Res.58(19), 4402–4409 (1998).
   PubMedGoogle Scholar
• Carlson JA, Slominski A, Linette GP et al. Malignant melanoma 2003: predisposition, diagnosis, prognosis, and staging. Am. J. Clin. Pathol.120(Suppl.), S101–S127 (2003).
   PubMedGoogle Scholar
• Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol. Rev.84(4), 1155–1228 (2004).
   PubMed Web of Science ®Google Scholar
• Wood SR, Berwick M, Ley RD, Walter RB, Setlow RB, Timmins GS. UV causation of melanoma in Xiphophorus is dominated by melanin photosensitized oxidant production. Proc. Natl Acad. Sci. USA103(11), 4111–4115 (2006).
   PubMedGoogle Scholar
• Tsai T, Vu C, Henson DE. Cutaneous, ocular and visceral melanoma in African Americans and Caucasians. Melanoma Res.15(3), 213–217 (2005).
   PubMed Web of Science ®Google Scholar
• Hu DN, Yu GP, McCormick SA, Schneider S, Finger PT. Population-based incidence of uveal melanoma in various races and ethnic groups. Am. J. Ophthalmol.140(4), 612–617 (2005).
   PubMed Web of Science ®Google Scholar
• Eide MJ, Weinstock MA. Association of UV index, latitude, and melanoma incidence in nonwhite populations-US Surveillance, Epidemiology, and End Results (SEER) program, 1992 to 2001. Arch. Dermatol.141(4), 477–481 (2005).
   PubMed Web of Science ®Google Scholar
• Elwood JM, Gallagher RP. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. Int. J. Cancer78(3), 276–280 (1998).
   PubMed Web of Science ®Google Scholar
• Slominski A, Wortsman J, Carlson A, Matsuoka L, Balch CM, Mihm M. Malignant melanoma: an update. Arch. Pathol. Lab. Med.125, 1295–1306 (2001).
   PubMed Web of Science ®Google Scholar
• Gandini S, Sera F, Cattaruzza MS et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur. J. Cancer41(1), 45–60 (2005).
   PubMed Web of Science ®Google Scholar
• Purdue MP, From L, Armstrong BK et al. Etiologic and other factors predicting nevus-associated cutaneous malignant melanoma. Cancer Epidemiol. Biomarkers Prev.14(8), 2015–2022 (2005).
   PubMed Web of Science ®Google Scholar
• Bulliard JL, Cox Belwood JM. Comparison of the site distribution of melanoma in New Zealand and Canada. Int. J. Cancer72(2), 231–235 (1997).
   PubMedGoogle Scholar
• Oliveria SA, Saraiya M, Geller AC, Heneghan MK, Jorgensen C. Sun exposure and risk of melanoma. Arch. Dis. Child.91(2), 131–138 (2006).
   PubMed Web of Science ®Google Scholar
• Hocker T, Tsao H. Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants. Hum. Mutat.28(6), 578–588 (2007).
   PubMed Web of Science ®Google Scholar
• Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J. Clin. Oncol.24(26), 4340–4346 (2006).
   PubMed Web of Science ®Google Scholar
• Bataille V, Bishop JA, Sasieni P et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br. J. Cancer73(12), 1605–1611 (1996).
   PubMed Web of Science ®Google Scholar
• Gefeller O, Tarantino J, Lederer P, Uter W, Pfahlberg AB. The relation between patterns of vacation sun exposure and the development of acquired melanocytic nevi in German children 6–7 years of age. Am. J. Epidemiol.165(10), 1162–1169 (2007).
   PubMed Web of Science ®Google Scholar
• Naldi L, Altieri A, Imberti GL, Gallus S, Bosetti C, La Vecchia C. Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy). Cancer Causes Control16(8), 893–899 (2005).
   PubMed Web of Science ®Google Scholar
• Carli P, Naldi L, Lovati S, La Vecchia C. The density of melanocytic nevi correlates with constitutional variables and history of sunburns: a prevalence study among Italian schoolchildren. Int. J. Cancer101(4), 375–379 (2002).
   PubMed Web of Science ®Google Scholar
• Monestier S, Gaudy C, Gouvernet J, Richard MA, Grob JJ. Multiple senile lentigos of the face, a skin ageing pattern resulting from a life excess of intermittent sun exposure in dark-skinned caucasians: a case–control study. Br. J. Dermatol.154(3), 438–444 (2006).
   PubMed Web of Science ®Google Scholar
• Bastiaens M, Hoefnagel J, Westendorp R, Vermeer BJ, Bouwes Bavinck JN. Solar lentigines are strongly related to sun exposure in contrast to ephelides. Pigment Cell. Res.17(3), 225–229 (2004).
   PubMedGoogle Scholar
• Kossard S. Atypical lentiginous junctional naevi of the elderly and melanoma. Australas. J. Dermatol.43(2), 93–101 (2002).
   PubMedGoogle Scholar
• Solomon CC, White E, Kristal AR, Vaughan T. Melanoma and lifetime UV radiation. Cancer Causes Control15(9), 893–902 (2004).
   PubMedGoogle Scholar
• Barlow JO, Maize J Sr, Lang PG. The density and distribution of melanocytes adjacent to melanoma and nonmelanoma skin cancers. Dermatol. Surg.33(2), 199–207 (2007).
   PubMed Web of Science ®Google Scholar
• Hendi A, Brodland DG, Zitelli JA. Melanocytes in long-standing sun-exposed skin: quantitative analysis using the ART-1 immunostain. Arch. Dermatol.142(7), 871–876 (2006).
   PubMedGoogle Scholar
• Cohen LM. Lentigo maligna and lentigo maligna melanoma. J. Am. Acad. Dermatol.33(6), 923–940 (1995).
   PubMed Web of Science ®Google Scholar
• Giehl KA, Nagele U, Volkenandt M, Berking C. Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma. J. Cutan. Pathol.34(1), 7–14 (2007).
   PubMed Web of Science ®Google Scholar
• Massi D, Carli P, Franchi A, Santucci M. Naevus-associated melanomas: cause or chance? Melanoma Res.9(1), 85–91 (1999).
   Google Scholar
• Whiteman DC, Stickley M, Watt P, Hughes MC, Davis MB, Green AC. Anatomic site, sun exposure, and risk of cutaneous melanoma. J. Clin. Oncol.24(19), 3172–3177 (2006).
   PubMed Web of Science ®Google Scholar
• Ley RD, Applegate LA, Padilla RS, Stuart TD. Ultraviolet radiation-induced malignant melanoma in monodelphis domestica. Photochem. Photobiol.50(1), 1–5 (1989).
   PubMed Web of Science ®Google Scholar
• Atillasoy ES, Seykora JT, Soballe PW et al. UVB induces atypical melanocytic lesions and melanoma in human skin. Am. J. Pathol.152(5), 1179–1186 (1998).
   PubMed Web of Science ®Google Scholar
• Setlow RB, Grist E, Thompson K, Woodhead AD. Wavelengths effective in induction of malignant melanoma. Proc. Natl Acad. Sci. USA90(14), 6666–6670 (1993).
   PubMed Web of Science ®Google Scholar
• de Laat A, van der Leun JC, de Gruijl FR. Carcinogenesis induced by UVA (365-nm) radiation: the dose-time dependence of tumor formation in hairless mice. Carcinogenesis18(5), 1013–1020 (1997).
   PubMed Web of Science ®Google Scholar
• Husain Z, Pathak MA, Flotte T, Wick MM. Role of ultraviolet radiation in the induction of melanocytic tumors in hairless mice following 7,12-dimethylbenz(a)anthracene application and ultraviolet irradiation. Cancer Res.51(18), 4964–4970 (1991).
   PubMed Web of Science ®Google Scholar
• van Schanke A, Jongsma MJ, Bisschop R, van Venrooij GM, Rebel H, de Gruijl FR. Single UVB overexposure stimulates melanocyte proliferation in murine skin, in contrast to fractionated or UVA-1 exposure. J. Invest. Dermatol.124(1), 241–247 (2005).
   PubMed Web of Science ®Google Scholar
• Klein-Szanto AJ, Silvers WK, Mintz B. Ultraviolet radiation-induced malignant skin melanoma in melanoma-susceptible transgenic mice. Cancer Res.54(17), 4569–4572 (1994).
   PubMedGoogle Scholar
• Noonan FP, Dudek J, Merlino G, De Fabo EC. Animal models of melanoma: an HGF/SF transgenic mouse model may facilitate experimental access to UV initiating events. Pigment Cell Res.16(1), 16–25 (2003).
   PubMedGoogle Scholar
• van Schanke A, van Venrooij GM, Jongsma MJ et al. Induction of nevi and skin tumors in Ink4a/Arf XPA knockout mice by neonatal, intermittent, or chronic UVB exposures. Cancer Res.66(5), 2608–2615 (2006).
   Google Scholar
• Recio JA, Noonan FP, Takayama H et al. Ink4a/Arf deficiency promotes ultraviolet radiation-induced melanomagenesis. Cancer Res.62(22), 6724–6730 (2002).
   PubMed Web of Science ®Google Scholar
• Hanawalt PC. Revisiting the rodent repairadox. Environ. Mol. Mutagen.38(2–3), 89–96 (2001).
   PubMed Web of Science ®Google Scholar
• Kunisada T, Lu SZ, Yoshida H et al. Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor. J. Exp. Med.187(10), 1565–1573 (1998).
   PubMed Web of Science ®Google Scholar
• Berking C, Takemoto R, Binder RL et al. Photocarcinogenesis in human adult skin grafts. Carcinogenesis23(1), 181–187 (2002).
   PubMed Web of Science ®Google Scholar
• Hussain SP, Harris CC. p53 biological network: at the crossroads of the cellular-stress response pathway and molecular carcinogenesis. J. Nippon. Med. Sch.73(2), 54–64 (2006).
   PubMedGoogle Scholar
• Jonason AS, Kunala S, Price GJ et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc. Natl Acad. Sci. USA93(24), 14025–14029 (1996).
   PubMed Web of Science ®Google Scholar
• Backvall H, Asplund A, Gustafsson A, Sivertsson A, Lundeberg J, Ponten F. Genetic tumor archeology: microdissection and genetic heterogeneity in squamous and basal cell carcinoma. Mutat. Res.571(1–2), 65–79 (2005).
   Google Scholar
• Ren ZP, Ahmadian A, Ponten F et al. Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin. Am. J. Pathol.150(5), 1791–1803 (1997).
   PubMedGoogle Scholar
• Carlson JA, Scott D, Wharton J, Sell S. Incidental histopathologic patterns: possible evidence of ‘field cancerization’ surrounding skin tumors. Am. J. Dermatopathol.23(5), 494–496 (2001).
   PubMed Web of Science ®Google Scholar
• Grady WM, Markowitz SD. Genetic and epigenetic alterations in colon cancer. Annu. Rev. Genomics Hum. Genet.3, 101–128 (2002).
   PubMed Web of Science ®Google Scholar
• Giglia-Mari G, Sarasin A. TP53 mutations in human skin cancers. Hum. Mutat.21(3), 217–228 (2003).
   PubMed Web of Science ®Google Scholar
• Cairns J. Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc. Natl Acad. Sci. USA99(16), 10567–10570 (2002).
   PubMed Web of Science ®Google Scholar
• Backvall H, Wolf O, Hermelin H, Weitzberg E, Ponten F. The density of epidermal p53 clones is higher adjacent to squamous cell carcinoma in comparison with basal cell carcinoma. Br. J. Dermatol.150(2), 259–266 (2004).
   Google Scholar
• Franco AV, Zhang XD, Van Berkel E et al. The role of NF-κB in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells. J. Immunol.166(9), 5337–5345 (2001).
   PubMed Web of Science ®Google Scholar
• Potten CS, Booth C. Keratinocyte stem cells: a commentary. J. Invest. Dermatol.119(4), 888–899 (2002).
   Google Scholar
• Zerp SF, van Elsas A, Peltenburg LT, Schrier PI. p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis. Br. J. Cancer79(5–6), 921–926 (1999).
   PubMedGoogle Scholar
• Jiang HW, Wortsman J, Matsuoka L et al. Molecular spectrum of pigmented skin lesions: from nevus to melanoma. Expert Rev. Dermatol.1(5), 679–700 (2006).
   Google Scholar
• Jensen UB, Lowell S, Watt FM. The spatial relationship between stem cells and their progeny in the basal layer of human epidermis: a new view based on whole-mount labelling and lineage analysis. Development126(11), 2409–2418 (1999).
   PubMed Web of Science ®Google Scholar
• Berg RJ, van Kranen HJ, Rebel HG et al. Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells. Proc. Natl Acad. Sci. USA93(1), 274–278 (1996).
   PubMed Web of Science ®Google Scholar
• Asplund A, Guo Z, Hu X, Wassberg C, Ponten F. Mosaic pattern of maternal and paternal keratinocyte clones in normal human epidermis revealed by analysis of X-chromosome inactivation. J. Invest. Dermatol.117(1), 128–131 (2001).
   Google Scholar
• Hartmann A, Blaszyk H, Cunningham JS et al. Overexpression and mutations of p53 in metastatic malignant melanomas. Int. J. Cancer67(3), 313–317 (1996).
   PubMedGoogle Scholar
• Zhang H. p53 plays a central role in UVA and UVB induced cell damage and apoptosis in melanoma cells. Cancer Lett.244(2), 229–238 (2006).
   PubMedGoogle Scholar
• Spatz A, Giglia-Mari G, Benhamou S, Sarasin A. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.Cancer Res.61(6), 2480–2486 (2001).
   PubMed Web of Science ®Google Scholar
• Purdue MP, From L, Kahn HJ et al. Etiologic factors associated with p53 immunostaining in cutaneous malignant melanoma. Int. J. Cancer117(3), 486–493 (2005).
   PubMed Web of Science ®Google Scholar
• Carlson JA, Slominski A, Linette GP, Mihm MC Jr, Ross JS. Biomarkers in melanoma: predisposition, screening and diagnosis. Expert Rev. Mol. Diagn.3(2), 163–184 (2003).
   PubMed Web of Science ®Google Scholar
• Wang JL, Zheng BY, Li XD et al. p16INK4A and p14ARF expression pattern by immunohistochemistry in human papillomavirus-related cervical neoplasia. Mod. Pathol.18(5), 629–637 (2005).
   PubMed Web of Science ®Google Scholar
• Soufir N, Moles JP, Vilmer C et al. p16 UV mutations in human skin epithelial tumors. Oncogene18(39), 5477–5481 (1999).
   Google Scholar
• Sarkar-Agrawal P, Vergilis I, Sharpless NE, DePinho RA, Runger TM. Impaired processing of DNA photoproducts and ultraviolet hypermutability with loss of p16INK4A or p19ARF. J. Natl Cancer Inst.96(23), 1790–1793 (2004).
   PubMedGoogle Scholar
• Gray-Schopfer VC, Karasarides M, Hayward R, Marais R. Tumor necrosis factor-α blocks apoptosis in melanoma cells when BRAF signaling is inhibited. Cancer Res.67(1), 122–129 (2007).
   PubMed Web of Science ®Google Scholar
• Thomas NE, Edmiston SN, Alexander A et al. Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiol. Biomarkers Prev.16(5), 991–997 (2007).
   PubMed Web of Science ®Google Scholar
• Gill M, Celebi JT. B-RAF and melanocytic neoplasia. J. Am. Acad. Dermatol.53(1), 108–114 (2005).
   PubMed Web of Science ®Google Scholar
• Thomas NE, Berwick M, Cordeiro-Stone M. Could BRAF mutations in melanocytic lesions arise from DNA damage induced by ultraviolet radiation? J. Invest. Dermatol.126(8), 1693–1696 (2006).
   PubMed Web of Science ®Google Scholar
• Lang J, MacKie RM. Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes. J. Invest. Dermatol.125(3), 575–579 (2005).
   PubMedGoogle Scholar
• Papp T, Schipper H, Kumar K, Schiffmann D, Zimmermann R. Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi. Melanoma Res.15(5), 401–407 (2005).
   Google Scholar
• Herlyn M, Berking C, Li G, Satyamoorthy K. Lessons from melanocyte development for understanding the biological events in naevus and melanoma formation. Melanoma Res.10(4), 303–312 (2000).
   Google Scholar
• Hung CF, Chiang HS, Lo HM, Jian JS, Wu WB. E-cadherin and its downstream catenins are proteolytically cleaved in human HaCaT keratinocytes exposed to UVB. Exp. Dermatol.15(4), 315–321 (2006).
   Google Scholar
• Nakazawa K, Nakazawa H, Bonnard M, Damour O, Collombel C. Ca2+ and UVB radiation have no effect on E-cadherin-mediated melanocyte-keratinocyte adhesion. Pigment Cell Res.8(5), 255–262 (1995).
   Google Scholar
• Pastila R, Leszczynski D. Ultraviolet A exposure alters adhesive properties of mouse melanoma cells. Photodermatol. Photoimmunol. Photomed.21(5), 234–241 (2005).
   Google Scholar
• Krengel S, Stark I, Geuchen C et al. Selective down-regulation of the α6-integrin subunit in melanocytes by UVB light. Exp. Dermatol.14(6), 411–419 (2005).
   PubMedGoogle Scholar
• Shellman YG, Makela M, Norris DA. Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines. Melanoma Res.16(3), 207–211 (2006).
   PubMed Web of Science ®Google Scholar
• Oh JH, Kim A, Park JM, Kim SH, Chung AS. Ultraviolet B-induced matrix metalloproteinase-1 and -3 secretions are mediated via PTEN/Akt pathway in human dermal fibroblasts. J. Cell. Physiol.209(3), 775–785 (2006).
   Google Scholar
• Poser I, Tatzel J, Kuphal S, Bosserhoff AK. Functional role of MIA in melanocytes and early development of melanoma. Oncogene23(36), 6115–6124 (2004).
   Google Scholar
• Bauer R, Humphries M, Fassler R, Winklmeier A, Craig SE, Bosserhoff AK. Regulation of integrin activity by MIA. J. Biol. Chem.281(17), 11669–11677 (2006).
   Google Scholar
• Marr DG, Poser I, Shellman YG, Bosserhoff AK, Norris DA. Ultraviolet radiation induces release of MIA: a new mechanism for UVR-induced progression of melanoma. Int. J. Oncol.25(1), 105–111 (2004).
   Google Scholar
• Dotto GP, Moellmann G, Ghosh S, Edwards M, Halaban R. Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment. J. Cell. Biol.109(6 Pt 1), 3115–3128 (1989).
   PubMedGoogle Scholar
• Wang T, Yang M, Chen J, Watkins T, Xiuyun C. Inhibition of B16 melanoma growth in vivo by retroviral vector-mediated human ribonuclease inhibitor. Angiogenesis8(1), 73–81 (2005).
   Google Scholar
• Berking C, Takemoto R, Satyamoorthy K et al. Induction of melanoma phenotypes in human skin by growth factors and ultraviolet B. Cancer Res.64(3), 807–811 (2004).
   PubMed Web of Science ®Google Scholar
• Wu CS, Yu CL, Wu CS, Lan CC, Yu HS. Narrow-band ultraviolet-B stimulates proliferation and migration of cultured melanocytes. Exp. Dermatol.13(12), 755–763 (2004).
   Google Scholar
• Hirobe T, Osawa M, Nishikawa S. Hepatocyte growth factor controls the proliferation of cultured epidermal melanoblasts and melanocytes from newborn mice. Pigment Cell Res.17(1), 51–61 (2004).
   Google Scholar
• Moretti S, Pinzi C, Spallanzani A et al. Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions. Int. J. Cancer84(2), 160–168 (1999).
   PubMed Web of Science ®Google Scholar
• Dissanayake NS, Mason RS. Modulation of skin cell functions by transforming growth factor-β1 and ACTH after ultraviolet irradiation. J. Endocrinol.159(1), 153–163 (1998).
   Google Scholar
• Kadono S, Manaka I, Kawashima M, Kobayashi T, Imokawa G. The role of the epidermal endothelin cascade in the hyperpigmentation mechanism of lentigo senilis. J. Invest. Dermatol.116(4), 571–577 (2001).
   Google Scholar
• Jamal S, Schneider RJ. UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells. J. Clin. Invest.110(4), 443–452 (2002).
   PubMedGoogle Scholar
• Trompezinski S, Pernet I, Mayoux C, Schmitt D, Viac J. Transforming growth factor-beta1 and ultraviolet A1 radiation increase production of vascular endothelial growth factor but not endothelin-1 in human dermal fibroblasts. Br. J. Dermatol.143(3), 539–545 (2000).
   Google Scholar
• Yano K, Kadoya K, Kajiya K, Hong YK, Detmar M. Ultraviolet B irradiation of human skin induces an angiogenic switch that is mediated by upregulation of vascular endothelial growth factor and by downregulation of thrombospondin-1. Br. J. Dermatol.152(1), 115–121 (2005).
   PubMed Web of Science ®Google Scholar
• Kosmadaki MG, Yaar M, Arble BL, Gilchrest BA. UV induces VEGF through a TNF-α independent pathway. FASEB J.17(3), 446–448 (2003).
   Google Scholar
• Shellman YG, Park YL, Marr DG et al. Release of vascular endothelial growth factor from a human melanoma cell line, WM35, is induced by hypoxia but not ultraviolet radiation and is potentiated by activated Ras mutation. J. Invest. Dermatol.121(4), 910–917 (2003).
   PubMed Web of Science ®Google Scholar
• Kim EJ, Park HY, Yaar M, Gilchrest BA. Modulation of vascular endothelial growth factor receptors in melanocytes. Exp. Dermatol.14(8), 625–633 (2005).
   PubMed Web of Science ®Google Scholar
• Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr. Rev.21(5), 457–487 (2000).
   PubMed Web of Science ®Google Scholar
• Slominski A, Wortsman J, Pisarchik A et al. Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J.15(10), 1678–1693 (2001).
   PubMed Web of Science ®Google Scholar
• Slominski A, Zbytek B, Pisarchik A, Slominski RM, Zmijewski MA, Wortsman J. CRH functions as a growth factor/cytokine in the skin. J. Cell Physiol.206(3), 780–791 (2006).
   PubMed Web of Science ®Google Scholar
• Zbytek B, Wortsman J, Slominski A. Characterization of a ultraviolet B-induced corticotropin-releasing hormone-proopiomelanocortin system in human melanocytes. Mol. Endocrinol.20(10), 2539–2547 (2006).
   PubMed Web of Science ®Google Scholar
• Chakraborty AK, Funasaka Y, Slominski A et al. UV light and MSH receptors. Ann. NY Acad. Sci.885, 100–116 (1999).
   PubMed Web of Science ®Google Scholar
• Im S, Moro O, Peng F et al. Activation of the cyclic AMP pathway by α-melanotropin mediates the response of human melanocytes to ultraviolet B radiation. Cancer Res.58(1), 47–54 (1998).
   PubMed Web of Science ®Google Scholar
• Slominski A, Zbytek B, Szczesniewski A et al. CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am. J. Physiol. Endocrinol. Metab.288(4), E701–E706 (2005).
   PubMed Web of Science ®Google Scholar
• Slominski A, Wortsman J, Tuckey RC, Paus R. Differential expression of HPA axis homolog in the skin. Mol. Cell. Endocrinol.265–266, 143–149 (2007).
   PubMed Web of Science ®Google Scholar
• Slominski A, Zbytek B, Szczesniewski A, Wortsman J. Cultured human dermal fibroblasts do produce cortisol. J. Invest. Dermatol.126(5), 1177–1178 (2006).
   PubMed Web of Science ®Google Scholar
• Slominski A, Wortsman J, Luger T, Paus R, Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol. Rev.80(3), 979–1020 (2000).
   PubMed Web of Science ®Google Scholar
• Zbytek B, Pfeffer LM, Slominski AT. CRH inhibits NF-κB signaling in human melanocytes. Peptides27(12), 3276–3283 (2006).
   PubMed Web of Science ®Google Scholar
• Zbytek B, Slominski AT. CRH mediates inflammation induced by lipopolysaccharide in human adult epidermal keratinocytes. J. Invest. Dermatol.127(3), 730–732 (2007).
   PubMed Web of Science ®Google Scholar
• Abdel-Malek Z, Swope VB, Suzuki I et al. Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc. Natl Acad. Sci. USA92(5), 1789–1793 (1995).
   PubMed Web of Science ®Google Scholar
• Lunec J, Pieron C, Thody AJ. MSH receptor expression and the relationship to melanogenesis and metastatic activity in B16 melanoma. Melanoma Res.2(1), 5–12 (1992).
   PubMed Web of Science ®Google Scholar
• Osman AM, Jansen PW, Smets LA, Benckhuijsen C. Glucocorticoid receptors and cell cycle progression in human melanoma cell lines. J. Cell Physiol.125(2), 306–312 (1985).
   Google Scholar
• Kimura M, Nishihira T, Kasai M, Sato H. Differentiative and proliferative effects of (But)2cAMP, N-butyric acid and prednisolone on the malignant melanoma cell line (TM-1) in vitro and in vivo.Tohoku J. Exp. Med.131(1), 29–35 (1980).
   Google Scholar
• Nathan C, Sporn M. Cytokines in context. J. Cell. Biol.113(5), 981–986 (1991).
   PubMed Web of Science ®Google Scholar
• Polsky D, Young AZ, Busam KJ, Alani RM. The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas. Cancer Res.61(16), 6008–6011 (2001).
   PubMedGoogle Scholar
• Zhang H, Rosdahl I. Ultraviolet A and B differently induce intracellular protein expression in human skin melanocytes – a speculation of separate pathways in initiation of melanoma. Carcinogenesis24(12), 1929–1934 (2003).
   PubMedGoogle Scholar
• Vile GF, Tanew-Ilitschew A, Tyrrell RM. Activation of NF-κB in human skin fibroblasts by the oxidative stress generated by UVA radiation. Photochem. Photobiol.62(3), 463–468 (1995).
   PubMed Web of Science ®Google Scholar
• Larsson P, Ollinger K, Rosdahl I. Ultraviolet (UV)A- and UVB-induced redox alterations and activation of nuclear factor-κB in human melanocytes-protective effects of α-tocopherol. Br. J. Dermatol.155(2), 292–300 (2006).
   Google Scholar
• Ivanov VN, Ronai Z. p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NF-κB activity and Fas expression. Oncogene19(26), 3003–3012 (2000).
   PubMedGoogle Scholar
• Holick MF, MacLaughlin JA, Clark MB et al. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science210(4466), 203–205 (1980).
   PubMed Web of Science ®Google Scholar
• Bikle DD. Vitamin D regulated keratinocyte differentiation. J. Cell. Biochem.92(3), 436–444 (2004).
   PubMed Web of Science ®Google Scholar
• Mason J, Mason AR, Cork MJ. Topical preparations for the treatment of psoriasis: a systematic review. Br. J. Dermatol.146(3), 351–364 (2002).
   PubMed Web of Science ®Google Scholar
• Sirulnik LA, Stone RM. Acute promyelocytic leukemia: current strategies for the treatment of newly diagnosed disease. Clin. Adv. Hematol. Oncol.3(5), 391–397, 429 (2005).
   Google Scholar
• James SY, Mercer E, Brady M, Binderup L, Colston KW. EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro.Br. J. Pharmacol.125(5), 953–962 (1998).
   PubMed Web of Science ®Google Scholar
• Evans TR, Colston KW, Lofts FJ et al. A Phase II trial of the vitamin D analogue seocalcitol (EB1089) in patients with inoperable pancreatic cancer. Br. J. Cancer86(5), 680–685 (2002).
   PubMed Web of Science ®Google Scholar
• Dalhoff K, Dancey J, Astrup L et al. A phase II study of the vitamin D analogue seocalcitol in patients with inoperable hepatocellular carcinoma. Br. J. Cancer89(2), 252–257 (2003).
   PubMed Web of Science ®Google Scholar
• Berwick M, Armstrong BK, Ben-Porat L et al. Sun exposure and mortality from melanoma. J. Natl Cancer Inst.97(3), 195–199 (2005).
   PubMed Web of Science ®Google Scholar
• Li C, Liu Z, Zhang Z et al. Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma. J. Invest. Dermatol.127(2), 276–280 (2007).
   PubMed Web of Science ®Google Scholar
• Barker JN, Mitra RS, Griffiths CE, Dixit VM, Nickoloff BJ. Keratinocytes as initiators of inflammation. Lancet337(8735), 211–214 (1991).
   PubMed Web of Science ®Google Scholar
• Karalis KP, Venihaki M, Zhao J, van Vlerken LE, Chandras C. NF-κB participates in the corticotropin-releasing, hormone-induced regulation of the pituitary proopiomelanocortin gene. J. Biol. Chem.279(12), 10837–10840 (2004).
   PubMed Web of Science ®Google Scholar